Robert Scott
Family Medicine · Asheboro, NCNPI 1831113778
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 96 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,207 and has fallen 98.8% since, to $14 in 2022.
Across 96 payments — averaging $13.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$183
- Novo Nordisk$132
- Boehringer Ingelheim$121
- Lilly USA, LLC$117
- Amarin Pharma, Inc.$95
- AbbVie$85
- plus $586 from 22 others
Across 1 payment — averaging $10,440 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$10K
What the payments were for
- Food & beverage$1,313100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 12 | $183 |
| Novo Nordisk | 12 | $132 |
| Boehringer Ingelheim | 7 | $121 |
| Lilly USA, LLC | 11 | $117 |
| Amarin Pharma, Inc. | 7 | $95 |
| AbbVie | 6 | $85 |
| GSK | 5 | $71 |
| Novartis | 4 | $54 |
| Amgen | 4 | $54 |
| Astellas Pharma US Inc | 4 | $48 |
| Neotract Inc. | 1 | $43 |
| Pfizer | 3 | $35 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $25 |
| Johnson & Johnson | 2 | $23 |
| Sanofi-aventis U.S. LLC | 2 | $22 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Valeritas, Inc. | 1 | $20 |
| Cranial Technologies, Inc | 1 | $17 |
| Aytu Biopharma, Inc. | 1 | $16 |
| Nevro Corp. | 1 | $16 |
| Sobi, Inc | 1 | $14 |
| Melinta Therapeutics, LLC | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
| Ironwood Pharmaceuticals, Inc | 1 | $13 |
| Merck | 1 | $11 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$1,319 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.
Other family medicine in Asheboro
- William CromwellRaleigh$879K
- Steve VacalisGastonia$693K
- David DundeeWinston Salem$633K
- Kevin SodenCharlotte$558K
- Brian ForrestApex$398K
- Joseph KonenCharlotte$322K
- Richard RachimaCharlotte$294K
- Dimitrios HondrosCharlotte$275K
- Domingo Rodriguez-CueGarner$253K
- Christopher ChaoCary$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.